Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 14, 2020

SELL
$264.77 - $305.71 $10.9 Million - $12.5 Million
-41,000 Closed
0 $0
Q2 2020

Jul 21, 2020

SELL
$258.66 - $342.55 $1.29 Million - $1.71 Million
-5,000 Reduced 10.87%
41,000 $9.77 Million
Q3 2019

Dec 03, 2019

SELL
$217.44 - $243.88 $3.26 Million - $3.66 Million
-15,000 Reduced 24.59%
46,000 $10.7 Million
Q1 2019

Apr 25, 2019

BUY
$216.71 - $338.96 $4.55 Million - $7.12 Million
21,000 Added 52.5%
61,000 $14.4 Million
Q2 2018

Jul 18, 2018

BUY
$257.52 - $306.91 $2.06 Million - $2.46 Million
8,000 Added 25.0%
40,000 $11.6 Million
Q3 2017

Nov 07, 2017

BUY
$281.15 - $329.69 $9 Million - $10.6 Million
32,000
32,000 $10 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Bedrijfstakpensioenfonds Voor De Media Pno Portfolio

Follow Bedrijfstakpensioenfonds Voor De Media Pno and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bedrijfstakpensioenfonds Voor De Media Pno, based on Form 13F filings with the SEC.

News

Stay updated on Bedrijfstakpensioenfonds Voor De Media Pno with notifications on news.